Proteomics of Cerebrospinal Fluid: Throughput and Robustness Using a Scalable Automated Analysis Pipeline for Biomarker Discovery.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Analytical Chemistry

• Publication date

  2015-10-16

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.analchem.5b02748PMID 26452177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry.

  2015cited by this paper
• An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease.

  2015cited by this paper
• In-depth Characterization of the Cerebrospinal Fluid (CSF) Proteome Displayed Through the CSF Proteome Resource (CSF-PR)*

  2014cited by this paper
• Protocadherins in neurological diseases.

  2014cited by this paper
• Multiplexed MRM with Internal Standards for Cerebrospinal Fluid Candidate Protein Biomarker Quantitation.

  2014cited by this paper
• ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination

  2014cited by this paper
• Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma.

  2014cited by this paper
• The Proteomics Identifications (PRIDE) database and associated tools: status in 2013

  2012cited by this paper
• Cell adhesion molecules contribute to Alzheimer’s disease: multiple pathway analyses of two genome‐wide association studies

  2012cited by this paper
• A Systematic Analysis of Eluted Fraction of Plasma Post Immunoaffinity Depletion: Implications in Biomarker Discovery

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Spectral counting assessment of protein dynamic range in cerebrospinal fluid following depletion with plasma-designed immunoaffinity columns

  2011cited by this paper
• Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people.

  2010cited by this paper
• Establishing the Proteome of Normal Human Cerebrospinal Fluid

  2010cited by this paper
• Depletion of abundant plasma proteins and limitations of plasma proteomics.

  2010cited by this paper
• Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease

  2009cited by this paper
• Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

  2008cited by this paper
• Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF).

  2008cited by this paper
• Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags.

  2008cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers

  2008cited by this paper
• Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis.

  2007cited by this paper
• 8‐Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease

  2007cited by this paper
• Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders

  2006cited by this paper
• Evaluation of protein depletion methods for the analysis of total-, phospho- and glycoproteins in lumbar cerebrospinal fluid.

  2005cited by this paper
• Proteomics analysis of human cerebrospinal fluid.

  2005cited by this paper
• Binding of RHOA G17V to p300 enhances its HAT activity: a new mechanism of epigenetic deregulation in TFH lymphoma

  1999cited by this paper
• Molecular Systems Biology Peer Review Process File Quantitative Variability of 342 Plasma Proteins in a Human Twin Population Transaction Report

  year unknowncited by this paper

• Cerebrospinal fluid protein biomarkers in Parkinson's disease.

  2024cites this paper
• Multiplexing the Identification of Microorganisms via Tandem Mass Tag Labeling Augmented by Interference Removal through a Novel Modification of the Expectation Maximization Algorithm

  2024cites this paper
• MS-Based Proteomics of Body Fluids: The End of the Beginning

  2023cites this paper
• Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer’s Disease

  2022cites this paper
• Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications

  2022cites this paper
• Methods to capture proteomic and metabolomic signatures from cerebrospinal fluid and serum of healthy individuals

  2022cites this paper
• Understanding the Intricate Role of Exosomes in Pathogenesis of Alzheimer’s Disease

  2022cites this paper
• Assessing normalization methods in mass spectrometry-based proteome profiling of clinical samples

  2022cites this paper
• Proteomics of Human Milk: Definition of a Discovery Workflow for Clinical Research Studies.

  2021cites this paper
• Pilot proteomic analysis of cerebrospinal fluid in Alzheimer's disease

  2021cites this paper
• Exploration of human cerebrospinal fluid: A large proteome dataset revealed by trapped ion mobility time-of-flight mass spectrometry

  2020cites this paper
• Comparison of normalization methods in clinical research applications of mass spectrometry-based proteomics

  2020cites this paper
• Recent Advances in Robotic Protein Sample Preparation for Clinical Analysis and Other Biomedical Applications.

  2020cites this paper
• Affinity depletion versus relative protein enrichment: a side-by-side comparison of two major strategies for increasing human cerebrospinal fluid proteome coverage

  2019cites this paper
• Hyphenated Mass Spectrometry Techniques in the Diagnosis of Amyloidosis.

  2019cites this paper
• Proteomes of Paired Human Cerebrospinal Fluid and Plasma: Relation to Blood-Brain Barrier Permeability in Older Adults.

  2019cites this paper
• Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.

  2019cites this paper
• In‐Depth Proteomic Analysis of Human Bronchoalveolar Lavage Fluid toward the Biomarker Discovery for Lung Cancers

  2019cites this paper
• Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry.

  2019cites this paper
• A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.

  2019cites this paper
• Alzheimer disease pathology and the cerebrospinal fluid proteome

  2018cites this paper
• Proteomic approach to profiling immune complex antigens in cerebrospinal fluid samples from patients with central nervous system autoimmune diseases.

  2018cites this paper
• Current and Future Applications of Biomedical Engineering for Proteomic Profiling: Predictive Biomarkers in Neuro-Traumatology

  2018influential citation
• An Adaptive Pipeline To Maximize Isobaric Tagging Data in Large-Scale MS-Based Proteomics.

  2018cites this paper
• Systematic Evaluation of the Use of Human Plasma and Serum for Mass-Spectrometry-Based Shotgun Proteomics.

  2018cites this paper
• Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.

  2018cites this paper
• Applications of Amine-Reactive Tandem Mass Tags (TMT) in Human Neuroproteomics

  2017cites this paper
• Current Proteomic Approaches Applied to Brain Function

  2017cites this paper
• A Highly Automated Shotgun Proteomic Workflow: Clinical Scale and Robustness for Biomarker Discovery in Blood.

  2017cites this paper
• Coordinated activation of mitochondrial respiration and exocytosis mediated by PKC signaling in pancreatic β cells

  2017cites this paper
• Biomarkers for prediction of cerebrovascular diseases associated complications and outcome

  2017cites this paper
• Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.

  2017cites this paper
• Preparation and Immunoaffinity Depletion of Fresh Frozen Tissue Homogenates for Mass Spectrometry-Based Proteomics in the Context of Drug Target/Biomarker Discovery.

  2017cites this paper
• Molecular delineation of cellular pathways associated with the antidepressant treatment response

  2016cites this paper
• Toward Biomarker Development in Large Clinical Cohorts: An Integrated High-Throughput 96-Well-Plate-Based Sample Preparation Workflow for Versatile Downstream Proteomic Analyses.

  2016cites this paper